US Stock MarketDetailed Quotes

MDGL Madrigal Pharmaceuticals

Watchlist
  • 315.480
  • -12.220-3.73%
Close May 2 16:00 ET
  • 315.480
  • 0.0000.00%
Post 20:01 ET
7.00BMarket Cap-17.68P/E (TTM)

About Madrigal Pharmaceuticals Company

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Company Profile

SymbolMDGL
Company NameMadrigal Pharmaceuticals
Listing DateFeb 6, 2007
Issue Price12.01
Founded2000
CEOMr. William John (Bill) Sibold
MarketNASDAQ
Employees528
Fiscal Year Ends12-31
AddressFour Tower Bridge,200 Barr Harbor Drive,Suite 200
CityWest Conshohocken
ProvincePennsylvania
CountryUnited States of America
Zip Code19428
Phone1-267-824-2827
Websitehttp://www.madrigalpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • William John (Bill) Sibold
  • Director, President and Chief Executive Officer
  • 32.27M
  • Carole Huntsman
  • Chief Commercial Officer
  • 3.14M
  • Dr. Robert E. Waltermire, PhD
  • Chief Pharmaceutical Development Officer
  • --
  • Mardi C. Dier
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Julian C. Baker
  • Chairman of the Board
  • 646.00K
  • Dr. Paul A. Friedman,M.D.
  • Director
  • 10.63K
  • Dr. Jacqualyn A. Fouse, PhD
  • Director
  • --
  • Dr. Rebecca A. Taub,M.D.
  • Director
  • 6.93M
  • Kenneth M. Bate
  • Independent Director
  • 383.63K
  • James M. Daly
  • Independent Director
  • 363.63K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 368.63K
  • Dr. Raymond Cheong, M.D.
  • Independent Director
  • 639.75K
  • Dr. Frederick B. Craves, PhD
  • Lead Independent Director
  • 371.13K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DexCom
DXCM
81.620
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
11.660
New Fortress Energy
NFE
6.080
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.310
5
Enerpac Tool
EPAC
41.900
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.